A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis
NCT02442570
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
recombinant human alpha B-crystallin
OTHER:
Placebo comparator
Sponsor
Delta Crystallon BV